Top hits include changes in transcriptional regulation (ZNF385B, SNORA65), tumour microenvironment (COL1A2, COL3A1), and metastatic processes (UCHL1, SUCNR1, THY1) (Fig. 2D). The gene discussed is ZNF385B; the disease is neoplasm.